Skip to main content
Premium Trial:

Request an Annual Quote

Toshiba Licenses DNA Chip Patents to Antara, Says Move is Major Step in Its IVD Plans

NEW YORK , March 10 (GenomeWeb News) - Antara Biosciences has licensed from Toshiba patents to its DNA chips and electrochemical DNA analysis system for in vitro diagnosis, Toshiba said today.

 

Under the agreement, Antara, a California-based company started by the Tokyo-based Eurus Genomics, will develop the products for US Food and Drug Administration approval.

 

Toshiba said the deal "is a major step ... toward establishing the methadology as a core methodology for DNA-based diagnostics."

 

Financial details were not released.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.